GRINX
Price
$21.44
Change
+$0.20 (+0.94%)
Updated
Jun 6 closing price
Net Assets
324.73M
VSTSX
Price
$282.92
Change
+$2.98 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

GRINX vs VSTSX

Header iconGRINX vs VSTSX Comparison
Open Charts GRINX vs VSTSXBanner chart's image
Victory Diversified Stock R
Price$21.44
Change+$0.20 (+0.94%)
VolumeN/A
Net Assets324.73M
Vanguard Total Stock Mkt Idx Instl Sel
Price$282.92
Change+$2.98 (+1.06%)
VolumeN/A
Net Assets1.82T
GRINX vs VSTSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GRINX vs. VSTSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRINX is a Buy and VSTSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.82T vs. GRINX (325M). VSTSX pays higher dividends than GRINX: VSTSX (1.29) vs GRINX (0.00). GRINX was incepted earlier than VSTSX: GRINX (26 years) vs VSTSX (9 years). GRINX (1.36) is less costly to investors than VSTSX (0.01). GRINX is a more actively managed with annual turnover of: 81.00 vs. VSTSX (2.00). GRINX has a lower initial minimum investment than VSTSX: GRINX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 10.98 vs. GRINX (2.31). VSTSX return over 5 years is better than : 81.06 vs. GRINX (30.88).
GRINXVSTSXGRINX / VSTSX
Total Expense Ratio1.360.0113,600%
Annual Report Gross Expense Ratio1.360.0113,600%
Fund Existence26 years9 years-
Gain YTD2.2140.839264%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets325M1.82T0%
Annual Yield % from dividends0.001.29-
Returns for 1 year2.3110.9821%
Returns for 3 years9.1140.4323%
Returns for 5 years30.8881.0638%
Returns for 10 years6.43N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTIX28.77N/A
N/A
Fidelity Advisor Biotechnology I
FEYIX27.80N/A
N/A
Fidelity Advisor Asset Manager 85% I
MNHRX25.79N/A
N/A
Manning & Napier Pro-Blend Max Term R
FWMNX17.06N/A
N/A
Fidelity Advisor Women's Leadership I
EEMHX8.78N/A
N/A
MFS Emerging Markets Equity Research R6